These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

692 related articles for article (PubMed ID: 34446045)

  • 41. Depletion of SLC7A11 Sensitizes Nasopharyngeal Carcinoma Cells to Ionizing Radiation.
    Yang F; Gong H; Chen S; Li J; Huang N; Wang M
    Protein Pept Lett; 2024; 31(4):323-331. PubMed ID: 38779733
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Expression and clinical significance of Nrf2 in esophageal squamous cell carcinoma].
    Mao JT; Tangsakar E; Shen H; Wang ZQ; Zhang MX; Chen JX; Zhang G; Wang JS
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Nov; 27(11):1231-3. PubMed ID: 22078454
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nrf2 attenuates ferroptosis-mediated IIR-ALI by modulating TERT and SLC7A11.
    Dong H; Xia Y; Jin S; Xue C; Wang Y; Hu R; Jiang H
    Cell Death Dis; 2021 Oct; 12(11):1027. PubMed ID: 34716298
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low-dose antimony exposure promotes prostate cancer proliferation by inhibiting ferroptosis via activation of the Nrf2-SLC7A11-GPX4 pathway.
    Shi J; Ma C; Zheng Z; Zhang T; Li Z; Sun X; He Z; Zhang Z; Zhang C
    Chemosphere; 2023 Oct; 339():139716. PubMed ID: 37562508
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SHP-1/STAT3-Signaling-Axis-Regulated Coupling between BECN1 and SLC7A11 Contributes to Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma.
    Huang CY; Chen LJ; Chen G; Chao TI; Wang CY
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232407
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NRF2 Antagonizes HIV-1 Tat and Methamphetamine-Induced BV2 Cell Ferroptosis by Regulating SLC7A11.
    Lin S; Cheng H; Yang G; Wang C; Leung CK; Zhang S; Tan Y; Zhang H; Wang H; Miao L; Li Y; Huang Y; Li J; Zhang R; Zeng X
    Neurotox Res; 2023 Oct; 41(5):398-407. PubMed ID: 37060393
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protocadherin 20 promotes ferroptosis by suppressing the expression of Sirtuin 1 and promoting the acetylation of nuclear factor erythroid 2-related factor 2 in hepatocellular carcinoma.
    Jun L; Chen W; Han L; Yanmin L; Qinglei Z; Pengfei Z
    Int J Biochem Cell Biol; 2023 Mar; 156():106363. PubMed ID: 36641129
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of MALT1 reduces ferroptosis in rat hearts following ischemia/reperfusion via enhancing the Nrf2/SLC7A11 pathway.
    Jiang YQ; Yang XY; Duan DQ; Zhang YY; Li NS; Tang LJ; Peng J; Luo XJ
    Eur J Pharmacol; 2023 Jul; 950():175774. PubMed ID: 37146710
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Blockage of Nrf2 suppresses the migration and invasion of esophageal squamous cell carcinoma cells in hypoxic microenvironment.
    Shen H; Yang Y; Xia S; Rao B; Zhang J; Wang J
    Dis Esophagus; 2014; 27(7):685-92. PubMed ID: 24028437
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dimethyl fumarate protects against hepatic ischemia-reperfusion injury by alleviating ferroptosis via the NRF2/SLC7A11/HO-1 axis.
    Qi D; Chen P; Bao H; Zhang L; Sun K; Song S; Li T
    Cell Cycle; 2023 Apr; 22(7):818-828. PubMed ID: 36482709
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bulk RNA-seq and scRNA-seq reveal SLC7A11, a key regulatory molecule of ferroptosis, is a prognostic-related biomarker and highly related to the immune system in lung adenocarcinoma.
    Wu X; Wang S; Chen K
    Medicine (Baltimore); 2023 Sep; 102(37):e34876. PubMed ID: 37713821
    [TBL] [Abstract][Full Text] [Related]  

  • 52. AKR1C3 suppresses ferroptosis in hepatocellular carcinoma through regulation of YAP/SLC7A11 signaling pathway.
    Chen J; Zhang J; Tian W; Ge C; Su Y; Li J; Tian H
    Mol Carcinog; 2023 Jun; 62(6):833-844. PubMed ID: 36920042
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NRF2/ACSS2 axis mediates the metabolic effect of alcohol drinking on esophageal squamous cell carcinoma.
    Odera JO; Xiong Z; Huang C; Gu N; Yang W; Githang'a J; Odera E; Paiboonrungruang C; Chen X
    Biochem J; 2020 Aug; 477(16):3075-3089. PubMed ID: 32776152
    [TBL] [Abstract][Full Text] [Related]  

  • 54. AURKA knockdown inhibits esophageal squamous cell carcinoma progression through ferroptosis.
    Mi Y; Chen L; Wang C; Miao Y; Song C; Su J; Wang L
    Heliyon; 2024 Apr; 10(7):e28365. PubMed ID: 38571661
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fostered Nrf2 expression antagonizes iron overload and glutathione depletion to promote resistance of neuron-like cells to ferroptosis.
    Liu Z; Lv X; Song E; Song Y
    Toxicol Appl Pharmacol; 2020 Nov; 407():115241. PubMed ID: 32937103
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibiting UHRF1 expression enhances radiosensitivity in human esophageal squamous cell carcinoma.
    Yang C; Wang Y; Zhang F; Sun G; Li C; Jing S; Liu Q; Cheng Y
    Mol Biol Rep; 2013 Sep; 40(9):5225-35. PubMed ID: 23943380
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long Noncoding RNA LINC00578 Inhibits Ferroptosis in Pancreatic Cancer via Regulating SLC7A11 Ubiquitination.
    Li H; Wei Y; Wang J; Yao J; Zhang C; Yu C; Tang Y; Zhu D; Yang J; Zhou J
    Oxid Med Cell Longev; 2023; 2023():1744102. PubMed ID: 36846713
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Brusatol induces ferroptosis in oesophageal squamous cell carcinoma by repressing GSH synthesis and increasing the labile iron pool via inhibition of the NRF2 pathway.
    Zhu X; Huang N; Ji Y; Sheng X; Huo J; Zhu Y; Huang M; He W; Ma J
    Biomed Pharmacother; 2023 Nov; 167():115567. PubMed ID: 37742602
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy.
    Koppula P; Zhuang L; Gan B
    Protein Cell; 2021 Aug; 12(8):599-620. PubMed ID: 33000412
    [TBL] [Abstract][Full Text] [Related]  

  • 60. GOLPH3 promotes tumor malignancy via inhibition of ferroptosis by upregulating SLC7A11 in cholangiocarcinoma.
    Yin Z; Liu Q; Gao Y; Wang R; Qi Y; Wang D; Chen L; Yin X; He M; Li W
    Mol Carcinog; 2024 May; 63(5):912-925. PubMed ID: 38390729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.